Inventor · disambiguated record
Andrew Zeitlin
Also filed as: ZEITLIN ANDREW · ZEITLIN ANDREW L
26 granted patents·26 pending applications·1,955 citations·filing 1989–2022
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US5837284ADelivery of multiple doses of medicationsFiled 1997·Granted Nov 17, 1998·552 cites·30 claims
- 0297US6528530B2Phenidate drug formulations having diminished abuse potentialCELGENE CORP·Filed 2001·Granted Mar 4, 2003·132 cites·4 claims
- 0397US6355656B1Phenidate drug formulations having diminished abuse potentialCELGENE CORP·Filed 1999·Granted Mar 12, 2002·147 cites·4 claims
- 0496US8263065B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2008·Granted Sep 11, 2012·31 cites·36 claims
- 0596US7700090B2Co-culture of placental stem cells and stem cells from a second sourceANTHROGENESIS CORP·Filed 2006·Granted Apr 20, 2010·71 cites·49 claims
- 0696US5908850AMethod of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jun 1, 1999·211 cites·4 claims
- 0795US7431944B2Delivery of multiple doses of medicationsCELGENE CORP·Filed 2003·Granted Oct 7, 2008·49 cites·6 claims
- 0895US6255325B1Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1999·Granted Jul 3, 2001·53 cites·1 claims
- 0994US6602887B2Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Aug 5, 2003·28 cites·8 claims
- 1093US8926964B2Methods of generating natural killer cellsHARIRI ROBERT J·Filed 2011·Granted Jan 6, 2015·28 cites·26 claims
- 1193US7115631B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2002·Granted Oct 3, 2006·39 cites·56 claims
- 1293US5346828AStereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolaseCELGENE CORP·Filed 1992·Granted Sep 13, 1994·55 cites·17 claims
- 1392US6635284B2Delivery of multiple doses of medicationsCELGENE CORP·Filed 1998·Granted Oct 21, 2003·102 cites·11 claims
- 1492US5169780AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1990·Granted Dec 8, 1992·89 cites·18 claims
- 1590US9464274B2Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2014·Granted Oct 11, 2016·13 cites·20 claims
- 1689US9216200B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2012·Granted Dec 22, 2015·5 cites·31 claims
- 1788US5733756ALactams and processes for stereoselective enrichment of lactams, amides, and estersCELGENE CORP·Filed 1996·Granted Mar 31, 1998·46 cites·20 claims
- 1888US5300437AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1992·Granted Apr 5, 1994·120 cites·16 claims
- 1988US4950606AEnantiomeric enrichment and stereoselective synthesis of chiral aminesCELGENE CORP·Filed 1989·Granted Aug 21, 1990·89 cites·20 claims
- 2087US8455250B2Co-culture of placental stem cells and stem cells from a second sourceHEIDARAN MOHAMMAD·Filed 2006·Granted Jun 4, 2013·11 cites·18 claims
- 2186US7479499B2Methods of using thalidomide in combination with irinotecanCELGENE CORP·Filed 2005·Granted Jan 20, 2009·6 cites·3 claims
- 2283US5922736AChronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jul 13, 1999·34 cites·10 claims
- 2382US7435726B2Compositions and methods for the treatment of cancerCELGENE CORP·Filed 2001·Granted Oct 14, 2008·14 cites·10 claims
- 2480US2010035928A1Method Of Treating Attention Deficit Disorders With D-Threo MethylphenidateZEITLIN ANDREW L·Filed 2009·Application pending·0 cites
- 2579US6914067B2Compositions and methods for the treatment of colorectal cancerCELGENE CORP·Filed 2001·Granted Jul 5, 2005·11 cites·19 claims
- 2678US2009088455A1Chronic, Bolus Adminstration Of D-Threo MethylphenidateCELGENE CORP·Filed 2008·Application pending·0 cites
- 2777US9200253B1Method of producing erythrocytesHEIDARAN MOHAMMAD A·Filed 2008·Granted Dec 1, 2015·4 cites·11 claims
- 2876US5985933AMethods for treating central and peripheral nerve painCELGENE CORP·Filed 1997·Granted Nov 16, 1999·15 cites·5 claims
- 2975US2022259563A1Methods of generating natural killer cellsCELULARITY INC·Filed 2022·Application pending·0 cites
- 3070US2010093797A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2009·Application pending·0 cites
- 3169US2006030587A1Method of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 2005·Application pending·0 cites
- 3269US2005119307A1Method of treating attention deficit disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 3367US2013109719A1Method of treating attention deficit disorders with d-threo methylphenidateZEITLIN ANDREW L·Filed 2012·Application pending·0 cites
- 3466US2021032596A1Method of producing erythrocytesCELULARITY INC·Filed 2020·Application pending·0 cites
- 3566US2011201645A1Method Of Treating Attention Deficit Disorders With D-Threo MethylphenidateZEITLIN ANDREW L·Filed 2011·Application pending·0 cites
- 3665US2005049279A1Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 3763US2019330592A1Methods of generating natural killer cellsCELULARITY INC·Filed 2019·Application pending·0 cites
- 3861US2013053414A1Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidateZELDIS JEROME B·Filed 2012·Application pending·0 cites
- 3961US2003232857A1Chronic, bolus administration of D-threo methylphenidateFiled 2003·Application pending·0 cites
- 4059US2008175824A1Co-culture of placental stem cells and stem cells from a second sourceHEIDARAN MOHAMMAD·Filed 2007·Application pending·0 cites
- 4159US2006183774A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2006·Application pending·0 cites
- 4259US2021121452A1Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compoundsCELULARITY INC·Filed 2020·Application pending·0 cites
- 4359US2005148524A1Compositions and methods for the treatment of cancerCELGENE CORP·Filed 2005·Application pending·0 cites
- 4458US2011257227A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2011·Application pending·0 cites
- 4557US2004204456A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 4656US2017002322A1Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 4756US2017240860A1Method of producing erythrocytesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 4853US2010143312A1Treatment of diseases, disorders or conditions of the lung using placental cellsHARIRI ROBERT J·Filed 2009·Application pending·0 cites
- 4952US2014341867A1Treatment of stroke using isolated placental cellsANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 5051US2016298084A1Co-culture of placental cells and stem cells from a second sourceHEIDARAN MOHAMMAD·Filed 2016·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrew Zeitlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →